Coeptis Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Coeptis Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $68.5K, a 142% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $68.5K +$40.2K +142% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $78K +$39.4K +102% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $87.1K +$38.6K +79.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $17.9K -$40.3K -69.2% Dec 31, 2021 10-Q 2022-11-08
Q3 2021 $28.4K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $38.5K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $48.5K Mar 31, 2021 10-Q/A 2021-05-18
Q4 2020 $58.2K Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.